Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
HLA-A*03 may confer protection against long COVID through an enhanced immune response
Eduardo Pons-Fuster, Rodrigo Martínez-Rodríguez, Lourdes Gimeno-Arias, et al.
Infectious Diseases Now (2025), pp. 105057-105057
Closed Access
The humoral and cellular response to mRNA SARS‐CoV ‐2 vaccine is influenced by HLA polymorphisms
Francesca Bertinetto, Paola Magistroni, G. Mazzola, et al.
HLA (2023) Vol. 102, Iss. 3, pp. 301-315
Open Access | Times Cited: 14
Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?
Mohammad Hossein Razizadeh, Alireza Zafarani, Mahsa Taghavi-Farahabadi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
The immunogenetics of COVID-19
Anshika Srivastava, Jill A. Hollenbach
Immunogenetics (2022) Vol. 75, Iss. 3, pp. 309-320
Open Access | Times Cited: 14
Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
HLA‐DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID‐19
Ticiana D.J. Farias, Silvia Brugiapaglia, Susanna Croci, et al.
HLA (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 6
The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection
Song Hu, Zuoyu Shao, Wei Ni, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19
Adrhyan Araújo, Gabriella Sgorlon, Letícia Ereira Aguiar, et al.
Experimental Biology and Medicine (2023) Vol. 248, Iss. 9, pp. 787-797
Open Access | Times Cited: 5
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population
Stefano Mocci, Roberto Littera, Stefania Tranquilli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province
Pramath Kakodkar, Pouneh Dokouhaki, Fang‐Xiang Wu, et al.
Human Immunology (2023) Vol. 84, Iss. 3, pp. 163-171
Open Access | Times Cited: 4
Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid
A. Balas, Miguel Á. Moreno‐Hidalgo, Fernando Calle, et al.
Human Immunology (2023) Vol. 84, Iss. 11, pp. 571-577
Closed Access | Times Cited: 3
The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to severe COVID-19 in the Iranian population
Narges Karami, Shaghik Barani, Mona Fani, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access
Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study
J. E. Niño‐Ramírez, Miguel Alcoceba, Ma Nieves Gutiérrez-Zufiaurre, et al.
HLA (2024) Vol. 104, Iss. 2
Closed Access
Association of KIR Genes with Middle East Respiratory Syndrome Coronavirus Infection in South Koreans
In‐Cheol Baek, Eun‐Jeong Choi, Hyoung‐Jae Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 258-258
Open Access
Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID‐19
Sudan Tao, Xuan You, Paul J. Norman, et al.
HLA (2024) Vol. 104, Iss. 4
Closed Access
Interferon-mediated NK cell activation is associated with limited neutralization breadth during SARS-CoV-2 infection
Izumi de los Rios Kobara, Radeesha Jayewickreme, Madeline Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The novel role of activating receptor KIR2DS5 in preeclampsia
Xiaoqi Wei, Xiuhua Yang
International Immunopharmacology (2023) Vol. 125, pp. 111087-111087
Open Access | Times Cited: 1
Association study between killer immunoglobulin-like receptor polymorphisms and susceptibility to COVID-19 disease: a systematic review and meta-analysis
Saeed Hosseini Teshnizi, Sara Mirzazadeh, Niloofar Mashhadi, et al.
Immunologic Research (2023) Vol. 72, Iss. 2, pp. 175-184
Closed Access | Times Cited: 1
The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer
Mina Roshan Zamir, Ali Ariafar, Abbas Ghaderi, et al.
Immunobiology (2022) Vol. 228, Iss. 2, pp. 152319-152319
Closed Access | Times Cited: 1
Role of T Helper 1 in COVID-19 Pathogenesis: Foe or Friend
Mehdi Yolmeh, Reza Ahmadi, Asyeh Yolmeh, et al.
International Journal of Enteric Pathogens (2023) Vol. 11, Iss. 4, pp. 140-150
Closed Access
Page 1

Scroll to top